Please login to the form below

Not currently logged in
Email:
Password:

IAS

This page shows the latest IAS news and features for those working in and with pharma, biotech and healthcare.

Biogen spin-out makes first acquisition

Biogen spin-out makes first acquisition

TNT009 is currently in a phase Ia/Ib study for CAD and also has potential in other diseases, including warm autoimmune haemolytic anaemia, antibody-mediated rejection of transplants and bullus pemphigoid

Latest news

More from news
Approximately 1 fully matching, plus 69 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics